• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青霉素结合蛋白1、2和3的突变是幽门螺杆菌对阿莫西林耐药的原因。

Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori.

作者信息

Rimbara Emiko, Noguchi Norihisa, Kawai Takashi, Sasatsu Masanori

机构信息

Department of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji-shi, Tokyo 192-0392, Japan.

出版信息

J Antimicrob Chemother. 2008 May;61(5):995-8. doi: 10.1093/jac/dkn051. Epub 2008 Feb 14.

DOI:10.1093/jac/dkn051
PMID:18276599
Abstract

OBJECTIVES

To elucidate the relationship between the mutations of penicillin-binding protein (PBP)1, PBP2 and PBP3 and amoxicillin resistance in Helicobacter pylori.

METHODS

The mutations detected only in clinical amoxicillin-resistant strains were determined by comparison of the deduced amino acid sequences of PBP1(HP0597), PBP2(HP1556) and PBP3(HP1565) encoded by the pbp1, ftsI and pbp2 genes, respectively, in 13 clinical H. pylori strains and three ATCC strains. The contribution of the mutations in PBPs was analysed by the natural transformation of the amoxicillin-susceptible strain ATCC 700392 with various combinations of the pbp1, ftsI and pbp2 genes from the amoxicillin-resistant strain TH743 (MIC of amoxicillin: 8 mg/L).

RESULTS

We initially identified six, four and two mutations of PBP1, PBP2 and PBP3, respectively, which were detected only in amoxicillin-resistant strains. By the natural transformation of an amoxicillin-susceptible strain ATCC 700392, we found that mutations in PBP1 and PBP3 conferred higher resistance to amoxicillin than mutations in PBP1 and PBP2, or mutations only in PBP1. Furthermore, mutations in PBP1, PBP2 and PBP3 conferred a 256-fold higher amoxicillin resistance when compared with ATCC 700392.

CONCLUSIONS

Multiple mutations in PBP2 and PBP3, in addition to mutations in PBP1, confer higher amoxicillin resistance in H. pylori.

摘要

目的

阐明幽门螺杆菌中青霉素结合蛋白(PBP)1、PBP2和PBP3的突变与阿莫西林耐药性之间的关系。

方法

通过比较分别由pbp1、ftsI和pbp2基因编码的PBP1(HP0597)、PBP2(HP1556)和PBP3(HP1565)的推导氨基酸序列,确定在13株临床幽门螺杆菌菌株和3株ATCC菌株中仅在临床阿莫西林耐药菌株中检测到的突变。通过用来自阿莫西林耐药菌株TH743(阿莫西林MIC:8mg/L)的pbp1、ftsI和pbp2基因的各种组合对阿莫西林敏感菌株ATCC 700392进行自然转化,分析PBPs中突变的作用。

结果

我们最初分别鉴定出PBP1、PBP2和PBP3的6个、4个和2个突变,这些突变仅在阿莫西林耐药菌株中检测到。通过对阿莫西林敏感菌株ATCC 700392进行自然转化,我们发现PBP1和PBP3中的突变比PBP1和PBP2中的突变或仅PBP1中的突变赋予更高的阿莫西林耐药性。此外,与ATCC 700392相比,PBP1、PBP2和PBP3中的突变赋予的阿莫西林耐药性高256倍。

结论

除PBP1中的突变外,PBP2和PBP3中的多个突变使幽门螺杆菌对阿莫西林具有更高的耐药性。

相似文献

1
Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori.青霉素结合蛋白1、2和3的突变是幽门螺杆菌对阿莫西林耐药的原因。
J Antimicrob Chemother. 2008 May;61(5):995-8. doi: 10.1093/jac/dkn051. Epub 2008 Feb 14.
2
Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.幽门螺杆菌基因rdxA和pbp1的突变会导致对甲硝唑和阿莫西林产生耐药性。
Antimicrob Agents Chemother. 2001 Mar;45(3):962-5. doi: 10.1128/AAC.45.3.962-965.2001.
3
Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori.青霉素结合蛋白1A保守的青霉素结合蛋白基序内或其附近的多个突变赋予幽门螺杆菌对阿莫西林的耐药性。
Helicobacter. 2006 Jun;11(3):181-7. doi: 10.1111/j.1523-5378.2006.00398.x.
4
[Detection of point mutation in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori].[一株体外筛选的幽门螺杆菌阿莫西林耐药菌株点突变的检测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Feb;29(2):166-72.
5
Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori.幽门螺杆菌青霉素结合蛋白1中的替换与阿莫西林耐药性之间的相关性。
Microbiol Immunol. 2007;51(10):939-44. doi: 10.1111/j.1348-0421.2007.tb03990.x.
6
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori.PBP1的变化与幽门螺杆菌临床分离株的阿莫西林耐药性有关。
J Antimicrob Chemother. 2002 Dec;50(6):849-56. doi: 10.1093/jac/dkf140.
7
Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates.由于等基因分离株中PBP-1A的点突变导致幽门螺杆菌对阿莫西林产生异质性耐药。
J Antimicrob Chemother. 2008 Mar;61(3):474-7. doi: 10.1093/jac/dkm504. Epub 2008 Jan 11.
8
Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori.幽门螺杆菌体外筛选的阿莫西林耐药菌株中的耐药机制
Antimicrob Agents Chemother. 2006 Dec;50(12):4174-6. doi: 10.1128/AAC.00759-06. Epub 2006 Sep 25.
9
Substitutions in penicillin-binding protein 1 in amoxicillin-resistant Helicobacter pylori strains isolated from Korean patients.从韩国患者中分离出的耐阿莫西林的幽门螺杆菌菌株中青霉素结合蛋白 1 的取代。
Gut Liver. 2013 Nov;7(6):655-60. doi: 10.5009/gnl.2013.7.6.655. Epub 2013 Aug 14.
10
Synergistic effects of novel penicillin-binding protein 1A amino acid substitutions contribute to high-level amoxicillin resistance of .新型青霉素结合蛋白 1A 氨基酸取代的协同作用导致 对阿莫西林的高水平耐药性。
mSphere. 2024 Aug 28;9(8):e0008924. doi: 10.1128/msphere.00089-24. Epub 2024 Aug 1.

引用本文的文献

1
Comparative Effects of Intermittent vs. Constant Ceftiofur Hydrochloride Exposure on In Vitro.间歇性与持续性暴露于盐酸头孢噻呋对体外的比较影响
Antibiotics (Basel). 2025 Jul 6;14(7):686. doi: 10.3390/antibiotics14070686.
2
Antibiotic Resistance and Genetic Determinants of in Oman: Insights from Phenotypic and Whole-Genome Analysis.阿曼抗生素耐药性及其遗传决定因素:来自表型和全基因组分析的见解
Int J Mol Sci. 2025 Jun 12;26(12):5628. doi: 10.3390/ijms26125628.
3
Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective.
幽门螺杆菌的抗生素耐药性:遗传学和生理学视角
Gut Pathog. 2025 May 23;17(1):35. doi: 10.1186/s13099-025-00704-5.
4
Amoxicillin high-dose dual therapy for primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which's better?阿莫西林高剂量双重疗法用于初次根除:质子泵抑制剂和钾离子竞争性酸阻滞剂,哪种更好?
World J Gastroenterol. 2025 Apr 7;31(13):100863. doi: 10.3748/wjg.v31.i13.100863.
5
resistance in Hainan Province, China: investigating phenotypes and genotypes through whole-genome sequencing.中国海南省的耐药性:通过全基因组测序研究表型和基因型。
Front Cell Infect Microbiol. 2024 Dec 17;14:1505166. doi: 10.3389/fcimb.2024.1505166. eCollection 2024.
6
Whole-genome sequencing analyses and antibiotic resistance situation of 48 Helicobacter pylori strains isolated in Zhejiang, China.中国浙江分离出的48株幽门螺杆菌的全基因组测序分析及抗生素耐药情况
Gut Pathog. 2024 Oct 23;16(1):62. doi: 10.1186/s13099-024-00656-2.
7
Clarithromycin sustained-release tablet may be an improper therapy for the eradication of .克拉霉素缓释片可能不是根除……的合适疗法。
Therap Adv Gastroenterol. 2024 Sep 14;17:17562848241275332. doi: 10.1177/17562848241275332. eCollection 2024.
8
Development and validation of next-generation sequencing panel for personalized eradication treatment targeting multiple species.开发和验证针对多种物种的个体化根除治疗的下一代测序 panel
Front Cell Infect Microbiol. 2024 Aug 29;14:1379790. doi: 10.3389/fcimb.2024.1379790. eCollection 2024.
9
Comparison of vonoprazan bismuth-containing triple therapy with quadruple therapy in Helicobacter pylori-infected treatment-naive patients: a prospective multicenter randomized controlled trial.沃克铋剂三联疗法与四联疗法治疗初治幽门螺杆菌感染患者的比较:一项前瞻性多中心随机对照试验
J Gastroenterol Hepatol. 2024 Nov;39(11):2293-2298. doi: 10.1111/jgh.16679. Epub 2024 Jul 16.
10
Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates.通过药敏试验和耐药分离株突变特征分析鉴定人胃内幽门螺杆菌异质性。
Sci Rep. 2024 May 27;14(1):12066. doi: 10.1038/s41598-024-62200-1.